 "Two stocks that Vaishali Parekh of Prabhudas Lilladher is bullish on")
BUY AUROBINDO PHARMA | CMP: Rs 1,009 | TARGET: Rs 1.150-1.200 | STOP LOSS: Rs 950
The stock has made a decent bottom near 950 level, forming a strong base, and has indicated a positive bullish candle pattern in the daily chart, moving past the significant 50-EMA level of 970 to further improve the bias. We anticipate an upward move in the coming days. The RSI is also showing a trend reversal and has signaled a buy. We suggest to buy and accumulate this stock for an upside target of 1,150-1,200 keeping the stop loss of 950. CLICK HERE FOR THE CHART
BUY MSTC | CMP: Rs 275 | TARGET: Rs 350-370 | STOP LOSS: Rs 255
The stock has been in a consolidation phase for quite some time maintaining the base near 255 levels and currently has given a bullish candle pattern in the daily chart to strengthen the bias. The stock has moved past the significant 50-EMA level of 269 to further improve the bias. Also, the RSI is indicating a trend reversal, making the chart look attractive. We suggest to buy and accumulate this stock for an upside target of 350-370 keeping the stop loss of 255. CLICK HERE FOR THE CHART
Disclaimer: The author is a technical analyst with Prabhudas Lilladher. She may have positions in one or more stocks mentioned above. Views are personal.
Disclaimer: The author is a technical analyst with Prabhudas Lilladher. She may have positions in one or more stocks mentioned above. Views are personal.
One subscription. Two world-class reads.
Already subscribed? Log in
Subscribe to read the full story →*Subscribe to Business Standard digital and get complimentary access to The New York Times
Smart Quarterly
₹900
3 Months
₹300/Month
SAVE 25%
Smart Essential
₹2,700
1 Year
₹225/Month
SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months
Super Saver
₹3,900
2 Years
₹162/Month
Subscribe
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
SAVE 25%